| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |